Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 43

Aledade aligns with corporates to raise $100m

GV-backed Aledade has secured series D funding at a $2.2bn post-money valuation to build out the business model for its primary care network.

Jan 21, 2021

Bloom & Wild makes room for $102m

Burda Principal Investments returned for a series D round that lifted flower delivery service Bloom & Wild's total funding to at least $130m.

Jan 18, 2021

Sennder secures $160m in series D round

Existing investor Scania co-led a series D round in which the trucking services platform developer achieved a valuation above $1bn.

Jan 15, 2021

Impulse Dynamics gets $60m implant

The Minth Group, Zoll Medical and Abiomed-backed medical device developer has raised at least $217m in total after closing additional series D funding.

Jan 15, 2021

Rapyd wraps up $300m series D

The Stripe-backed cross-border payment platform developer more than doubled its valuation to $2.5bn in the Coatue-led round.

Jan 14, 2021

M-Service embraces nine-figure series D round

The Standard Chartered-backed owner of digital wallet Momo will use the funding to launch its own strategic investment subsidiary.

Jan 14, 2021

Workato serves up $110m series D

The Workday, Salesforce and ServiceNow-backed workflow automation software provider boosted its valuation to $1.7bn and its overall funding to over $220m.

Jan 13, 2021

Komodo loads up on $44m

The McKesson-backed software provider secured $44m in series D funding alongside the acquisition of healthcare software developer Mavens.

Jan 12, 2021

Mambu ambles to $135m round

The Commerzbank-backed financial services software provider's valuation now tops $2bn, TCV having led its latest round.

Jan 12, 2021

Abbisko absorbs $123m in series D round

Lilly Asia Ventures, a regional corporate venturing subsidiary of pharmaceutical firm Eli Lilly, reinvested in a round set to accelerate development of Abbisko's cancer-focused drug candidates.

Jan 12, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here